Report Detail
Global Nanotechnology for Healthcare Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4604534 |
- 02 August, 2024 |
- Global |
- 144 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Nanotechnology for Healthcare market size was valued at USD 233730 million in 2023 and is forecast to a readjusted size of USD 465820 million by 2030 with a CAGR of 10.4% during review period.
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 102 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
The nanotechnology for healthcare market is driven by its potential to revolutionize medical diagnosis, treatment, and drug delivery through precise targeting at the nanoscale level. Nanotechnology enables the development of innovative therapies, such as nanoparticles for drug delivery and nanosensors for early disease detection, promising enhanced treatment outcomes and reduced side effects. However, there are challenges to address, including concerns about the safety and toxicity of nanoparticles, regulatory hurdles, and the high cost of research and development. Ensuring the safe and responsible use of nanotechnology in healthcare, along with comprehensive regulations, will be vital to harness its full potential. Additionally, collaborations between researchers, healthcare professionals, and regulatory bodies will play a crucial role in overcoming these challenges and advancing the field of nanotechnology in healthcare.
The Global Info Research report includes an overview of the development of the Nanotechnology for Healthcare industry chain, the market status of Anticancer (Nanomedicine, Nano Medical Devices), CNS Product (Nanomedicine, Nano Medical Devices), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nanotechnology for Healthcare.
Regionally, the report analyzes the Nanotechnology for Healthcare markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nanotechnology for Healthcare market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nanotechnology for Healthcare market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nanotechnology for Healthcare industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Nanomedicine, Nano Medical Devices).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nanotechnology for Healthcare market.
Regional Analysis: The report involves examining the Nanotechnology for Healthcare market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nanotechnology for Healthcare market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nanotechnology for Healthcare:
Company Analysis: Report covers individual Nanotechnology for Healthcare players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nanotechnology for Healthcare This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Anticancer, CNS Product).
Technology Analysis: Report covers specific technologies relevant to Nanotechnology for Healthcare. It assesses the current state, advancements, and potential future developments in Nanotechnology for Healthcare areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nanotechnology for Healthcare market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nanotechnology for Healthcare market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Market segment by Application
Anticancer
CNS Product
Anti-infective
Other
Market segment by players, this report covers
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Bristol-Myers Squibb
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Kirin
Servier Pharmaceuticals
Ipsen
Endo International
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nanotechnology for Healthcare product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nanotechnology for Healthcare, with revenue, gross margin and global market share of Nanotechnology for Healthcare from 2019 to 2024.
Chapter 3, the Nanotechnology for Healthcare competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nanotechnology for Healthcare market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanotechnology for Healthcare.
Chapter 13, to describe Nanotechnology for Healthcare research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Nanotechnology for Healthcare
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Nanotechnology for Healthcare by Type
- 1.3.1 Overview: Global Nanotechnology for Healthcare Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Nanotechnology for Healthcare Consumption Value Market Share by Type in 2023
- 1.3.3 Nanomedicine
- 1.3.4 Nano Medical Devices
- 1.3.5 Nano Diagnosis
- 1.3.6 Other
- 1.4 Global Nanotechnology for Healthcare Market by Application
- 1.4.1 Overview: Global Nanotechnology for Healthcare Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Anticancer
- 1.4.3 CNS Product
- 1.4.4 Anti-infective
- 1.4.5 Other
- 1.5 Global Nanotechnology for Healthcare Market Size & Forecast
- 1.6 Global Nanotechnology for Healthcare Market Size and Forecast by Region
- 1.6.1 Global Nanotechnology for Healthcare Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Nanotechnology for Healthcare Market Size by Region, (2019-2030)
- 1.6.3 North America Nanotechnology for Healthcare Market Size and Prospect (2019-2030)
- 1.6.4 Europe Nanotechnology for Healthcare Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Nanotechnology for Healthcare Market Size and Prospect (2019-2030)
- 1.6.6 South America Nanotechnology for Healthcare Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Nanotechnology for Healthcare Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Amgen
- 2.1.1 Amgen Details
- 2.1.2 Amgen Major Business
- 2.1.3 Amgen Nanotechnology for Healthcare Product and Solutions
- 2.1.4 Amgen Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Amgen Recent Developments and Future Plans
- 2.2 Teva Pharmaceuticals
- 2.2.1 Teva Pharmaceuticals Details
- 2.2.2 Teva Pharmaceuticals Major Business
- 2.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Product and Solutions
- 2.2.4 Teva Pharmaceuticals Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Teva Pharmaceuticals Recent Developments and Future Plans
- 2.3 Abbott
- 2.3.1 Abbott Details
- 2.3.2 Abbott Major Business
- 2.3.3 Abbott Nanotechnology for Healthcare Product and Solutions
- 2.3.4 Abbott Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Abbott Recent Developments and Future Plans
- 2.4 UCB
- 2.4.1 UCB Details
- 2.4.2 UCB Major Business
- 2.4.3 UCB Nanotechnology for Healthcare Product and Solutions
- 2.4.4 UCB Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 UCB Recent Developments and Future Plans
- 2.5 Roche
- 2.5.1 Roche Details
- 2.5.2 Roche Major Business
- 2.5.3 Roche Nanotechnology for Healthcare Product and Solutions
- 2.5.4 Roche Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Roche Recent Developments and Future Plans
- 2.6 Bristol-Myers Squibb
- 2.6.1 Bristol-Myers Squibb Details
- 2.6.2 Bristol-Myers Squibb Major Business
- 2.6.3 Bristol-Myers Squibb Nanotechnology for Healthcare Product and Solutions
- 2.6.4 Bristol-Myers Squibb Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
- 2.7 Sanofi
- 2.7.1 Sanofi Details
- 2.7.2 Sanofi Major Business
- 2.7.3 Sanofi Nanotechnology for Healthcare Product and Solutions
- 2.7.4 Sanofi Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Sanofi Recent Developments and Future Plans
- 2.8 Merck & Co
- 2.8.1 Merck & Co Details
- 2.8.2 Merck & Co Major Business
- 2.8.3 Merck & Co Nanotechnology for Healthcare Product and Solutions
- 2.8.4 Merck & Co Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Merck & Co Recent Developments and Future Plans
- 2.9 Biogen
- 2.9.1 Biogen Details
- 2.9.2 Biogen Major Business
- 2.9.3 Biogen Nanotechnology for Healthcare Product and Solutions
- 2.9.4 Biogen Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Biogen Recent Developments and Future Plans
- 2.10 Stryker
- 2.10.1 Stryker Details
- 2.10.2 Stryker Major Business
- 2.10.3 Stryker Nanotechnology for Healthcare Product and Solutions
- 2.10.4 Stryker Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Stryker Recent Developments and Future Plans
- 2.11 Gilead Sciences
- 2.11.1 Gilead Sciences Details
- 2.11.2 Gilead Sciences Major Business
- 2.11.3 Gilead Sciences Nanotechnology for Healthcare Product and Solutions
- 2.11.4 Gilead Sciences Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Gilead Sciences Recent Developments and Future Plans
- 2.12 Pfizer
- 2.12.1 Pfizer Details
- 2.12.2 Pfizer Major Business
- 2.12.3 Pfizer Nanotechnology for Healthcare Product and Solutions
- 2.12.4 Pfizer Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 Pfizer Recent Developments and Future Plans
- 2.13 3M Company
- 2.13.1 3M Company Details
- 2.13.2 3M Company Major Business
- 2.13.3 3M Company Nanotechnology for Healthcare Product and Solutions
- 2.13.4 3M Company Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.13.5 3M Company Recent Developments and Future Plans
- 2.14 Johnson & Johnson
- 2.14.1 Johnson & Johnson Details
- 2.14.2 Johnson & Johnson Major Business
- 2.14.3 Johnson & Johnson Nanotechnology for Healthcare Product and Solutions
- 2.14.4 Johnson & Johnson Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.14.5 Johnson & Johnson Recent Developments and Future Plans
- 2.15 Smith & Nephew
- 2.15.1 Smith & Nephew Details
- 2.15.2 Smith & Nephew Major Business
- 2.15.3 Smith & Nephew Nanotechnology for Healthcare Product and Solutions
- 2.15.4 Smith & Nephew Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.15.5 Smith & Nephew Recent Developments and Future Plans
- 2.16 Leadiant Biosciences
- 2.16.1 Leadiant Biosciences Details
- 2.16.2 Leadiant Biosciences Major Business
- 2.16.3 Leadiant Biosciences Nanotechnology for Healthcare Product and Solutions
- 2.16.4 Leadiant Biosciences Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.16.5 Leadiant Biosciences Recent Developments and Future Plans
- 2.17 Kyowa Kirin
- 2.17.1 Kyowa Kirin Details
- 2.17.2 Kyowa Kirin Major Business
- 2.17.3 Kyowa Kirin Nanotechnology for Healthcare Product and Solutions
- 2.17.4 Kyowa Kirin Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.17.5 Kyowa Kirin Recent Developments and Future Plans
- 2.18 Servier Pharmaceuticals
- 2.18.1 Servier Pharmaceuticals Details
- 2.18.2 Servier Pharmaceuticals Major Business
- 2.18.3 Servier Pharmaceuticals Nanotechnology for Healthcare Product and Solutions
- 2.18.4 Servier Pharmaceuticals Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.18.5 Servier Pharmaceuticals Recent Developments and Future Plans
- 2.19 Ipsen
- 2.19.1 Ipsen Details
- 2.19.2 Ipsen Major Business
- 2.19.3 Ipsen Nanotechnology for Healthcare Product and Solutions
- 2.19.4 Ipsen Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.19.5 Ipsen Recent Developments and Future Plans
- 2.20 Endo International
- 2.20.1 Endo International Details
- 2.20.2 Endo International Major Business
- 2.20.3 Endo International Nanotechnology for Healthcare Product and Solutions
- 2.20.4 Endo International Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019-2024)
- 2.20.5 Endo International Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Nanotechnology for Healthcare Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Nanotechnology for Healthcare by Company Revenue
- 3.2.2 Top 3 Nanotechnology for Healthcare Players Market Share in 2023
- 3.2.3 Top 6 Nanotechnology for Healthcare Players Market Share in 2023
- 3.3 Nanotechnology for Healthcare Market: Overall Company Footprint Analysis
- 3.3.1 Nanotechnology for Healthcare Market: Region Footprint
- 3.3.2 Nanotechnology for Healthcare Market: Company Product Type Footprint
- 3.3.3 Nanotechnology for Healthcare Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Nanotechnology for Healthcare Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Nanotechnology for Healthcare Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Nanotechnology for Healthcare Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Nanotechnology for Healthcare Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Nanotechnology for Healthcare Consumption Value by Type (2019-2030)
- 6.2 North America Nanotechnology for Healthcare Consumption Value by Application (2019-2030)
- 6.3 North America Nanotechnology for Healthcare Market Size by Country
- 6.3.1 North America Nanotechnology for Healthcare Consumption Value by Country (2019-2030)
- 6.3.2 United States Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 6.3.3 Canada Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Nanotechnology for Healthcare Consumption Value by Type (2019-2030)
- 7.2 Europe Nanotechnology for Healthcare Consumption Value by Application (2019-2030)
- 7.3 Europe Nanotechnology for Healthcare Market Size by Country
- 7.3.1 Europe Nanotechnology for Healthcare Consumption Value by Country (2019-2030)
- 7.3.2 Germany Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 7.3.3 France Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 7.3.5 Russia Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 7.3.6 Italy Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Nanotechnology for Healthcare Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Nanotechnology for Healthcare Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Nanotechnology for Healthcare Market Size by Region
- 8.3.1 Asia-Pacific Nanotechnology for Healthcare Consumption Value by Region (2019-2030)
- 8.3.2 China Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 8.3.3 Japan Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 8.3.5 India Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 8.3.7 Australia Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Nanotechnology for Healthcare Consumption Value by Type (2019-2030)
- 9.2 South America Nanotechnology for Healthcare Consumption Value by Application (2019-2030)
- 9.3 South America Nanotechnology for Healthcare Market Size by Country
- 9.3.1 South America Nanotechnology for Healthcare Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Nanotechnology for Healthcare Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Nanotechnology for Healthcare Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Nanotechnology for Healthcare Market Size by Country
- 10.3.1 Middle East & Africa Nanotechnology for Healthcare Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
- 10.3.4 UAE Nanotechnology for Healthcare Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Nanotechnology for Healthcare Market Drivers
- 11.2 Nanotechnology for Healthcare Market Restraints
- 11.3 Nanotechnology for Healthcare Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Nanotechnology for Healthcare Industry Chain
- 12.2 Nanotechnology for Healthcare Upstream Analysis
- 12.3 Nanotechnology for Healthcare Midstream Analysis
- 12.4 Nanotechnology for Healthcare Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Nanotechnology for Healthcare. Industry analysis & Market Report on Nanotechnology for Healthcare is a syndicated market report, published as Global Nanotechnology for Healthcare Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Nanotechnology for Healthcare market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
